Skip to main content
. 2023 May 14;12(23):2300305. doi: 10.1002/adhm.202300305

Figure 2.

Figure 2

Design of the in vivo experiments: a) timeline of the in vivo hydrogel degradation (by MRI) and biocompatibility experiment; b) timeline of the [89Zr]Zr‐AuNPs hydrogel release and biodistribution study (by PET); and c) timeline of the study to demonstrate the radiosensitizing effect on xenograft tumors, of AuNP‐releasing hydrogels applied by a 3D‐printed subcutaneous implant.